ETIHX Mutual Fund

NAV$57.84

Fund Essentials - as of Dec 31, 2025

Net Assets
$1.4B
Expense Ratio
1.31%
Dividend Yield (Current)
-
Holdings
90
Inception Date
Dec 27, 2012
Fund Family
Eventide
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+13.50%
1 Year+71.76%
3 Year+15.76%
5 Year+6.76%
10 Year+15.18%

Asset Allocation

Stocks: 93.43%
Bonds: 0.01%
Cash: 0.22%
Other: 6.34%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
GHGuardant Health Inccommon Stock4.46%
MIRMMirum Pharmaceuticals, Inc.3.60%
BBNXBeta Bionics Inc_None_None3.19%
INSMInsmed Inc Common Stock3.15%
-Ginnie Mae Ii Pool 3.5%11/20/20473.11%
Top 10 Concentration: 30.70%Report Date: Dec 31, 2025
Download all 90 holdings for ETIHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$4.47
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how ETIHX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

ETIHX Mutual Fund Overview

ETIHX Mutual Fund (Eventide Healthcare & Life Sciences Fund Class I) is managed by Eventide with $1.43B in net assets. ETIHX expense ratio is 1.31%, holding 90 positions across sectors including Health Care, Other, Unknown. Inception date: 2012-12-27.

ETIHX performance shows a YTD return of 13.50%. The 1-year return is 71.76% and the 5-year return is 6.76%.

ETIHX top holdings include Guardant Health Inccommon Stock (4.5%), Mirum Pharmaceuticals, Inc. (3.6%), Beta Bionics Inc_None_None (3.2%), Insmed Inc Common Stock (3.1%), Ginnie Mae Ii Pool 3.5%11/20/2047 (3.1%). View all ETIHX holdings, sector breakdown, or dividend history.

ETIHX can be compared against other funds using the overlap calculator or side-by-side comparison tool. ETIHX alternatives are available via the screener, along with tax-loss harvesting opportunities.